Hereditary cystatin C amyloid angiopathy

References

• Glenner G G, Murphey M A. Amyloidosis of the nervous system. J Neurol Sci 1989; 94: 1–28
   PubMed Web of Science ®Google Scholar
• Vinters H V. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311–24
   PubMed Web of Science ®Google Scholar
• Haan J, Roos R AC. Amyloid in central nervous system disease. Clin Neurol Neurosurg 1990; 92: 305–10
   PubMedGoogle Scholar
• Haan J, Maat-Schieman M LC, Roos R AC. Clinical effects of cerebral amyloid angiopathy. Dementia 1994; 5: 210–3
   PubMedGoogle Scholar
• Van Broeckhoven C, Haan J, Bakker E, Hardy J A, Van Hul W, Wehnert A, Vegter-Van Der Vlis M, Roos R AC. Amyloid p protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990; 248: 1120–2
   PubMed Web of Science ®Google Scholar
• Levy E, Carman M D, Fernandez-Madrid I, Lieberburg I, Power M D, van Duinen S G, Bots G TAM, Luyendijk W, Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248: 1124–6
   PubMed Web of Science ®Google Scholar
• Hendriks L, Van Duijn C M, Cras P, Cruts M, Van Hul W, Van Harskamp F, Warren A, McInnes M G, Anatonarakis S E, Martin J J, Hofinan A, Van Broeckhoven C. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of beta-amyloid precursor protein gene. Nat Genet 1992; 1: 218–21
   PubMed Web of Science ®Google Scholar
• Kametani F, Dceda S, Yangisawa N, Ishi T, Hanyu N. Characterization of a transthyretui-related amyloid fibril protein from cerebral amyloid angiopathy type I familial amyloid polyneuropathy. J Neurol Sci 1992; 108: 178–83
   PubMed Web of Science ®Google Scholar
• Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow M R, Dlouhy S R, Tagliavini F. Prion protein amyloidosis. Brain Pathol 1996; 6: 127–45
   PubMed Web of Science ®Google Scholar
• Arnason A. Apoplexie und ihre vererbung (thesis). Acta Psychiat Neurol 1935, suppl VII
   Google Scholar
• Gudmundsson G, Hallgrimsson J, Jònasson T A, Bjarnason S. Hereditary cerebral haemorrhage with amyloidosis. Brain 1972; 95: 387–404
   PubMed Web of Science ®Google Scholar
• Jensson O, Thorsteinsson L, Palsdottir A, Gudmundsson G, Arnasson A, Blöndal H, Abrahamson M, Grubb A, Olafsson I, Lundwall Å. An isolate of families with hereditary cystatin C amyloid angiopathy and cerebral haemorrhage in the south of Iceland. Amyloid and Amyloidosis, T Isobe, S Araki, F Uchino, S Kito, E Tsubura. Plenum Publishing Corp., New York 1988; 579–84
   Google Scholar
• Jensson Ó, Gudmundsson G, Árnason A, Blöndal H, Pétursdóttir I, Thorsteinsson L, Grubb A, Löfberg H, Cohen D, Frangione B. Hereditary cystatin C (y-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 1987; 76: 102–14
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Olafsson E, Blöndal H, Arnason A, Heuser W A. Hereditary cerebral hemorrhage in Iceland. Incidence for the 35 year period 1960-1994. Icelandic Med J suppl 1998; 37: 76
   Google Scholar
• Graffagnino C, Herbstreith M H, Schmechel D E, Levy E, Roses A D, Alberts M J. Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke 1995; 25: 2190–3
   Google Scholar
• McCarron M O, Nicoll J AR, Stewart J, Ironside J W, Mann D MA, Love S, Graham D I, Grubb A. Cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology 1999, in press
   Google Scholar
• Sveinbjornsdottir S, Blondal H, Gudmundsson G, Kjartansson O, Jonsdottir S, Gudmundsson G. Progressive dementia and leucoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopatho-logical presentation of two cases. J Neurol Sci 1996; 140: 101–8
   PubMed Web of Science ®Google Scholar
• Lofberg H, Grubb A O, Nilsson E K, Jensson Ó, Gudmundsson G, Blondal H, Árnason A, Thorsteinsson L. Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 1987; 18: 431–40
   PubMed Web of Science ®Google Scholar
• Thorsteinsson L, Blöndal H, Jensson Ó, Gudmundsson G. Distribution of cystatin C amyloid deposits in the Icelandic patients with hereditary cystatin C amyloid angiopathy. Amyloid and Amyloidosis, T Isobe, S Araki, F Uchino, S Kito, E Tsubura. Plenum Publishing Corp., New York 1988; 585–90
   Google Scholar
• Wang Z Z, Jensson O, Thorsteinsson L, Vinters H V. Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS 1997; 105: 41–7
   PubMedGoogle Scholar
• Benedikz E, Blondal H, Gudmundsson G. Skin deposits in hereditary cystatin C amyloidosis. Virchows Archiv A 1990; 417: 325–31
   Google Scholar
• Jensson O, Gudmundsson G, Arnason A, Blöndal H, Grubb A, Lofberg H. Hereditary central nervous system y-trace amyloid angiopathy and stroke in Icelandic families. Amyloidosis, G G Glenner, E F Ossserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Publishing Corp., New York 1986; 585–90
   Google Scholar
• Rowe I F, Jensson O, Lewis P D, Candy J, Tennent G A, Pepys M B. Immunohistochemical demonstration of amyloid P component in cerebrovascular amyloidosis. Neuropathol Appl Neurobiol 1984; 10: 53–61
   PubMedGoogle Scholar
• Maruyama K, Ikeda S, Ishihara T, Allsop D, Yanagiswa N. Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to β protein and cystatin C. Stroke 1990; 21: 397–403
   PubMed Web of Science ®Google Scholar
• Haan J, Maat-Schieman M LC, Van Duinen S G, Jensson ó, Thorsteinsson L, Roos R AC. Colocalization of A4 and cystatin C in cortical blood vessels in Dutch but not in Icelandic hereditary cerebral angiopathy with amyloidosis. Acta Neurol Scand 1994; 89: 367–71
   PubMed Web of Science ®Google Scholar
• Shimode K, Kobayashi S, Imoka K, Umage N, Nagai A. Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke 1996; 27: 1417–9
   PubMed Web of Science ®Google Scholar
• Vinters H V, Secor D L, Pardridge W M, Gray F. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoen-cephalopathy. Ann Neurol 1990; 28: 34–42
   PubMed Web of Science ®Google Scholar
• Anders K H, Wang Z Z, Kornfeld M, Gray F, Soontornniyomkij V, Reed L A, Hart M N, Menchine M, Secor D L, Vinters H V. Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol 1997; 28: 1237–46
   PubMed Web of Science ®Google Scholar
• Maruyama K, Kametani F, Ikeda S, Ishihara T, Yanagisawa N. Characterization of amyloid protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both P protein and cystatin C. Neurosci Lett 1992; 144: 38–42
   PubMed Web of Science ®Google Scholar
• Cohen D H, Feiner H, Jensson ó, Frangione B. Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med 1983; 158: 623–8
   PubMed Web of Science ®Google Scholar
• Grubb A, Löfberg H. Human trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982; 79: 3024–7
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Grubb A, Ólafsson Í, Lundwall Å. Molecular cloning and sequence analysis of a cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett 1987; 216: 229–33
   PubMed Web of Science ®Google Scholar
• Turk V, Brzin J, Longer M, Ritonja A, Eropkin M. Protein inhibitors of cysteine proteinases III. Amino acid sequence of cystatin from chicken egg white. Hoppe-Seyler's Z Physiol Chem 1983; 364: 1487–96
   PubMedGoogle Scholar
• Schwabe C, Anastasi A, Crow H, McDonald J K, Barrett A. Cystatin: Amino acid sequence and possible secondary structure. Biochem J 1984; 217: 813–7
   PubMedGoogle Scholar
• Bode W, Engh R, Musil D, Thiele U, Huber R, Karashikov A, Brzin J, Kos J, Turk V. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO 1988; 7: 2593–9
   PubMed Web of Science ®Google Scholar
• Dieckmann T, Mitschang L, Hofmann M, Kos J, Turk V, Auerswald E A, Jaenicke R, Oschkinat H. The structures of native chicken cystatin and of a recombinant unphosphorylated variant in solution. J Mol Biol 1993; 234: 104859
   Google Scholar
• Ekiel I, Abrahamson M, Fulton D B, Lindahl P, Storer A C, Levadoux W, Lafrance M, Labelle S, Pomerleau Y, Groleau D, LeSauteur L, Gehring K. NMR structural studies of human cystatin C dimers and monomers. J Mol Biol 1997; 271: 266–77
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Barrett A J, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 1986; 261: 11281–9
   Google Scholar
• Abrahamson M, Ritonja A, Brown M A, Grubb A, Machleidt W, Barrett A J. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem 1987; 262: 9688–94
   PubMed Web of Science ®Google Scholar
• Hall A, Håkansson K, Mason R W, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 1995; 270: 5115–21
   PubMed Web of Science ®Google Scholar
• Hall A, Ekiel I, Mason R W, Kasprzykowski F, Grubb A, Abrahamson M. Structural basis for different inhibitory specificities of human cystatins C and D. Biochemistry 1998; 37: 4071–9
   PubMed Web of Science ®Google Scholar
• Hall A, Dalbøge H, Grubb A, Abrahamson M. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem J 1993; 291: 123–9
   PubMed Web of Science ®Google Scholar
• Björk I, Brieditis I, Raub-Segall E, Pol E, Håkansson K, Abrahamson M. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Tip-106 variants of the inhibitor with cysteine proteinases. Biochemistry 1996; 35: 10720–6
   PubMed Web of Science ®Google Scholar
• Mason R W, Sol-Church K, Abrahamson M. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J 1998; 330: 833–8
   PubMed Web of Science ®Google Scholar
• Lindahl P, Ripoll D, Abrahamson M, Mort J S, Storer A C. Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B. Biochemistry 1994; 33: 4384–9
   PubMed Web of Science ®Google Scholar
• Grubb A, Abrahamson M, Olafsson I, Trojnar J, Kasprzykowska R, Kasprzykowski F, Grzonka Z. Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C. Biol Chem Hoppe Seyler 1990; 371(Suppl)137–44
   PubMedGoogle Scholar
• Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R, Kasprzykowski F. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. J Enzyme Inhib 1992; 6: 113–23
   PubMed Web of Science ®Google Scholar
• Björck L, Åkesson P, Bohus M, Trojnar J, Abrahamson M, Olafsson I, Grubb A. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 1989; 337: 385–6
   PubMed Web of Science ®Google Scholar
• Björck L, Grubb A, Kjellen L, Cystatin C. A human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990; 64: 941–3
   PubMed Web of Science ®Google Scholar
• Chen J M, Dando P M, Rawlings N D, Brown M A, Young N E, Stevens R A, Hewitt E, Watts C, Barrett A J. Cloning, isolation and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chemistry 1997; 272: 8090–8
   PubMed Web of Science ®Google Scholar
• Alvarez-Fernandez M, Barrett A J, Gerhartz B, Dando P M, Ni J, Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem 1999; 21A: 5–203, 1919
   Google Scholar
• Barrett A J, Davies M E, Grubb A. The place of human y-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984; 120: 631–6
   PubMed Web of Science ®Google Scholar
• Rawlings N D, Barrett A J. Evolution of proteins of the cystatin superfamily. J Mol Evol 1990; 30: 60–71
   PubMed Web of Science ®Google Scholar
• Freije J P, Abrahamson M, Olafsson I, Velasco G, Grubb A, Lopez-Otin C. Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J Biol Chem 1991; 266: 20538–43
   PubMed Web of Science ®Google Scholar
• Sotiropoulou G, Anisowicz A, Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem 1997; 272: 903–10
   PubMed Web of Science ®Google Scholar
• Ni J, Abrahamson Zhang M, Fernandez M A, Grubb A, Su J, Yu G-L, Li Y, Parmelee D, Xing L, Coleman T A, Gentz S, Thotakura R, Nguyen N, Hesselberg M, Gentz R. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997; 272: 10853–8
   PubMed Web of Science ®Google Scholar
• Ni J, Fernandez M A, Danielsson L, Chillakuru R A, Zhang J, Grubb A, Su J, Gentzrand Abrahamson M. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 1998; 273: 24797–804
   PubMed Web of Science ®Google Scholar
• Ohkubo I, Kurachi K, Takasawa T, Shiokawa H, Sasaki M. Isolation of a human cDNA for α2-thiol proteinase inhibitor and its identity with low molecular weight kinino-gen. Biochemistry 1984; 23: 5691–7
   PubMed Web of Science ®Google Scholar
• Müller-Esterl W, Fritz H, Machleidt W, Ritonja A, Brzin J, Kotnik M, Turk V, Kellerman J, Lottspeich F. Human plasma kininogens are identical with a-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. FEBS Lett 1985; 182: 310–4
   PubMed Web of Science ®Google Scholar
• Barrett A J. The cystatins: a new class of peptidase inhibitors. Trends Biochem Sci 1987; 12: 193–6
   Web of Science ®Google Scholar
• Abrahamson M, Islam M Q, Szpirer J, Szpirer C, Levan G. The human cystatin C gene (CST3) mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Hum Genet 1989; 82: 223–6
   PubMed Web of Science ®Google Scholar
• Schnittger S, Rao Gopal V V N, Abrahamson M, Hansmann I. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p 11.2. Genomics 1993; 16: 50–5
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Ólafsson Í, Pálsdóttir Å, Ulvsbäck M, Lundwall Å, Jensson Ó, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287–94
   PubMed Web of Science ®Google Scholar
• Ólafsson Í. The human cystatin C gene promoter: functional analysis and identification of heterogenous mRNA. ScandJClin Lab Invest 1995; 55: 597–609
   PubMed Web of Science ®Google Scholar
• Emilsson V, Thorsteinsson L, Jensson Ó, Gudmundsson G. Human cystatin C gene expression and regulation by TGFβ1: Implications for the pathogenesis of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Amyloid: Int J Exp Clin Invest 1996; 3: 110–8
   Web of Science ®Google Scholar
• Solem M, Rawson C, Lindburg K, Barnes D. Transforming growth factor beta regulates cystatin C in serum free mouse embryo (SFME) cells. Biochem Biophys Res Commun 1990; 172: 945–51
   PubMed Web of Science ®Google Scholar
• Bjarnadóttir M, Grubb A, Ólafsson Í. Promotermediated, dexamethasone-induced increase in cystatin C production by HeLa cells. ScandJ Clin Lab Invest 1995; 55: 617–23
   PubMed Web of Science ®Google Scholar
• Warfel A H, Zucker-Franklin D, Frangione B, Ghiso J. Constitutive secretion of cystatin C (trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med 1987; 166: 1912–7
   PubMed Web of Science ®Google Scholar
• Warfel A H, Cardozo C, Yoo O H, Zucker-Franklin D. Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukocyte Biol 1991; 49: 41–7
   PubMed Web of Science ®Google Scholar
• Chapman H A, Reilly J J, Yee R, Grubb A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis 1990; 141: 698–705
   PubMed Web of Science ®Google Scholar
• Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta MedScand 1985; 218: 499–503
   PubMed Web of Science ®Google Scholar
• Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921–6
   PubMed Web of Science ®Google Scholar
• Newman D J, Thakkar H, Edwards R G, Wilkie M, White T, Grubb A O, Price C P. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Internal 1995; 47: 312–8
   PubMed Web of Science ®Google Scholar
• Grubb A, Jensson Ó, Gudmundsson G, Årnason A, Löfberg H, Malm J. Abnormal metabolism of trace alkaline microprotein: The basic defect in hereditary cerebral hemorrhage with amyloidosis. New Engl J Med 1984; 311: 1547–9
   PubMed Web of Science ®Google Scholar
• Ólafsson Í, Gudmundsson G, Abrahamson M, Jensson Ó, Grubb A. The amino terminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated: direct sequence analysis from agarose gel electropherograms. Scand J Clin Lab Invest 1990; 50: 85–93
   PubMedGoogle Scholar
• Ghiso J, Jensson S, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986; 83: 2974–8
   PubMed Web of Science ®Google Scholar
• Pálsdóttir Å, Abrahamson M, Thorsteinsson L, Årnason A, Ólafsson Í, Grubb A, Jensson Ó. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988; ii: 603–4
   Google Scholar
• Abrahamson M, Jónsdóttir S, Ólafsson Í, Jensson Ó, Grubb A. Hereditary cystatin C amyloid angiopathy: Identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 1992; 89: 377–80
   PubMed Web of Science ®Google Scholar
• Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteinases. J Exp Med 1989; 169: 1771–8
   PubMedGoogle Scholar
• Abrahamson M, Dalböge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native biologically active human cystatin C in Escherichia coli. FEBS Lett 1988; 236: 14–8
   PubMed Web of Science ®Google Scholar
• Dalbøge H, Jensen E B, Tottrup H, Grubb A, Abrahamson M, Olafsson I, Carlsen S. High-level expression of active human cystatin C in Escherichia coli. Gene 1989; 79: 325–32
   PubMed Web of Science ®Google Scholar
• Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of (Leu 68 Gln)cystatin C, the amyloid forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 1994; 91: 1416–20
   PubMed Web of Science ®Google Scholar
• Gerhartz B, Ekiel I, Abrahamson M. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry 1998; 37: 17309–17
   PubMed Web of Science ®Google Scholar
• Ekiel I, Abrahamson M. Folding-related dimerization of human cystatin C. J Biol Chem 1996; 271: 1314–21
   PubMed Web of Science ®Google Scholar
• Merz G S, Benedikz E, Schwenk V, Johansen T E, Vogel L K, Rushbrook J I, Wisniewski H M. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 1997; 173: 423–32
   PubMed Web of Science ®Google Scholar
• Bjarnadottir M, Wulff B S, Sameni M, Sloane B F, Keppler D, Grubb A, Abrahamson M. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol Pathol 1998; 5l: 317–26
   Google Scholar
• Benedikz E, Merz G S, Schwenk V, Johansen T E, Wisniewski H M, Rushbrook J I. Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Amyloid: Int J Exp Clin Invest 1999; 6: 172–82
   PubMed Web of Science ®Google Scholar
• Wei L, Berman Y, Castano E M, Cadene M, Beavis R C, Devi L, Levy E. Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Biol Chem 1998; 273: 11806–14
   PubMed Web of Science ®Google Scholar
• Thorsteinsson L, Georgsson G, Åsgeirsson B, Bjarnadóttir M, Ólafsson Í, Jensson Ó, Gudmundsson G. On the role of monocytes/macrophages in the pathogenesis of central nervous system lesion in hereditary cystatin C amyloid angiopathy. J Neurol Sci 1992; 108: 121–8
   PubMed Web of Science ®Google Scholar
• Perutz M F. Mutations make enzyme polymerize. Nature 1997; 385: 773–5
   PubMed Web of Science ®Google Scholar
• Fink A L. Chaperone-mediated protein folding. Physiol Rev 1999; 79: 425–49
   PubMed Web of Science ®Google Scholar
• Booth D R, Sunde M, Bellotti V, Robinson C V, Hutchinson W L, Fraser P E, Hawkins P N, Dobson C M, Radford S E, Blake C CF, Pepys M B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997; 385: 787–93
   PubMed Web of Science ®Google Scholar
• Bellotti V, Mangione P, Stoppini M. Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 1999; 55: 977–91
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Aucouturier P, Soto C, Frangione B. The prionoses and other conformational disorders. Amyloid: Int J Exp Clin Invest 1998; 5: 212–24
   PubMed Web of Science ®Google Scholar
• Aridor M, Balch W E. Integration of endoplasmic reticulum signaling in health and disease. Nat Med 1999; 5: 745–51
   PubMed Web of Science ®Google Scholar
• Carell R W, Lomas D A. Conformational disease. Lancet 1997; 350: 134–8
   PubMedGoogle Scholar
• Shi G P, Sukhova G K, Grubb A, Ducharme A, Rhode L H, Lee R T, Ridker P M, Libby P, Chapman H A. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191–7
   PubMed Web of Science ®Google Scholar
• Lomas D A, Evans D L, Finch J T, Carrell R W. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 1992; 357: 605–7
   PubMed Web of Science ®Google Scholar
• Findeis M A, Musso G M, Arico-Muendel C, Benjamin H W, Hundal A M, Lee J J, Chin J, Kelley M, Wakefield J, Hayward N J, Molineaux S M. Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry 1999; 38: 6791–800
   PubMed Web of Science ®Google Scholar
• Soto C, Sigurdsson E M, Morelli L, Kumar R A, Castano E M, Frangione B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 1998; 4: 822–6
   PubMed Web of Science ®Google Scholar
• Cummings C J, Manchini M A, Antalffy B, DeFranco D B, Orr H T, Zoghbi H Y. Chaperone suppression of aggregation and altered proteasome localization imply misfolding in SCA1. Nat Genet 1998; 19: 148–54
   PubMed Web of Science ®Google Scholar
• Loo T W, Clarke D M. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J Biol Chem 1997; 272: 709–12
   PubMed Web of Science ®Google Scholar